Joan C. Galceran
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Evolving landscape of targeted therapies in early phase clinical trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 04, 2026
Enhanced RNA-targeting CRISPR-Cas technology in zebrafish.
Journal: bioRxiv : the preprint server for biology
Published: October 17, 2024
Enhanced RNA-targeting CRISPR-Cas technology in zebrafish.
Journal: Nature communications
Published: July 13, 2024
Publisher Correction: Intron detention tightly regulates the stemness/differentiation switch in the adult neurogenic niche.
Journal: Nature communications
Published: April 24, 2024
Two distinct epithelial-to-mesenchymal transition programs control invasion and inflammation in segregated tumor cell populations.
Journal: Nature cancer
Published: March 16, 2023
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials.
Journal: Med (New York, N.Y.)
Published: January 22, 2023
Intron detention tightly regulates the stemness/differentiation switch in the adult neurogenic niche.
Journal: Nature communications
Published: December 06, 2021
MicroRNAs Establish the Right-Handed Dominance of the Heart Laterality Pathway in Vertebrates.
Journal: Developmental cell
Published: October 18, 2018
A right-handed signalling pathway drives heart looping in vertebrates.
Journal: Nature
Published: July 19, 2016
Acetylcholinesterase modulates presenilin-1 levels and γ-secretase activity.
Journal: Journal of Alzheimer's disease : JAD
Published: April 05, 2014
Last Updated: 09/26/2026